QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bullock, C. M. Articles by Zhou, Q.-Y. Search for Related Content PubMed PubMed Citation Articles by Bullock, C. M. Articles by Zhou, Q.-Y.

Structural Determinants Required for the Bioactivities of Prokineticins and Identification of Prokineticin Receptor Antagonists

Department of Pharmacology, University of California, Irvine, California

Prokineticins are cysteine-rich secreted proteins that regulate diverse biological processes, including gastrointestinal motility, angiogenesis, and circadian rhythms. Two closely related G protein-coupled receptors that mediate signal transduction of prokineticins have recently been cloned. The structural elements required for prokineticins' bioactivities are still unknown. We show here that both the N-terminal hexapeptide (AVITGA) and C-terminal cysteine-rich domains are critical for the bioactivities of prokineticins. Substitutions, deletions, and insertions to the conserved N-terminal hexapeptides result in the loss of agonist activity. Mutant prokineticins with the substitution of the first N-terminal alanine with methionine or the addition of a methionine to the N terminus inhibit the activation of prokineticin receptors and thus are considered as antagonists of prokineticin receptors. We have further shown that mutations in selected cysteine residues in the C-terminal domain result in prokineticins without biological activity. The essential role of C-terminal domain is reinforced by two observations: that peptides without the carboxyl domain and proteins with the N-terminal hexapeptide fused to the carboxyl domains of colipase or dickkopf are devoid of biological activity. We demonstrate that limited structural changes of C-terminal cysteine-rich regions of prokineticins are tolerable because chimeric prokineticins with swapped cysteine-rich domains between prokineticin 1 and prokineticin 2, as well as a splice variant of prokineticin 2 that contains extra 21 residue insertion in its C-terminal domain, are biologically active.

Address correspondence to: Dr. Qun-Yong Zhou, Department of Pharmacology, University of California, Irvine, CA 92697. E-mail: qzhou{at}uci.edu

This article has been cited by other articles:

				M. Fry, G. T. Cottrell, and A. V. Ferguson Prokineticin 2 influences subfornical organ neurons through regulation of MAP kinase and the modulation of sodium channels Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R848 - R856. [Abstract] [Full Text] [PDF]

				J. Evans, R. D. Catalano, K. Morgan, H. O. D. Critchley, R. P. Millar, and H. N. Jabbour Prokineticin 1 Signaling and Gene Regulation in Early Human Pregnancy Endocrinology, June 1, 2008; 149(6): 2877 - 2887. [Abstract] [Full Text] [PDF]

				N. Pitteloud, C. Zhang, D. Pignatelli, J.-D. Li, T. Raivio, L. W. Cole, L. Plummer, E. E. Jacobson-Dickman, P. L. Mellon, Q.-Y. Zhou, et al. From the Cover: Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism PNAS, October 30, 2007; 104(44): 17447 - 17452. [Abstract] [Full Text] [PDF]

				K. Urayama, C. Guilini, N. Messaddeq, K. Hu, M. Steenman, H. Kurose, G. Ert, and C. G. Nebigil The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis FASEB J, September 1, 2007; 21(11): 2980 - 2993. [Abstract] [Full Text] [PDF]

				Q.-Y. Zhou The Prokineticins: A NOVEL PAIR OF REGULATORY PEPTIDES Mol. Interv., December 1, 2006; 6(6): 330 - 338. [Abstract] [Full Text] [PDF]

				L. Negri, R. Lattanzi, E. Giannini, M. Colucci, F. Margheriti, P. Melchiorri, V. Vellani, H. Tian, M. De Felice, and F. Porreca Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J. Neurosci., June 21, 2006; 26(25): 6716 - 6727. [Abstract] [Full Text] [PDF]

				S.-i. Matsumoto, C. Yamazaki, K.-h. Masumoto, M. Nagano, M. Naito, T. Soga, H. Hiyama, M. Matsumoto, J. Takasaki, M. Kamohara, et al. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. PNAS, March 14, 2006; 103(11): 4140 - 4145. [Abstract] [Full Text] [PDF]

				K. L. Ng, J.-D. Li, M. Y. Cheng, F. M. Leslie, A. G. Lee, and Q.-Y. Zhou Dependence of Olfactory Bulb Neurogenesis on Prokineticin 2 Signaling Science, June 24, 2005; 308(5730): 1923 - 1927. [Abstract] [Full Text] [PDF]

				J. Chen, C. Kuei, S. Sutton, S. Wilson, J. Yu, F. Kamme, C. Mazur, T. Lovenberg, and C. Liu Identification and Pharmacological Characterization of Prokineticin 2{beta} as a Selective Ligand for Prokineticin Receptor 1 Mol. Pharmacol., June 1, 2005; 67(6): 2070 - 2076. [Abstract] [Full Text] [PDF]

				I. Soderhall, Y.-A Kim, P. Jiravanichpaisal, S.-Y. Lee, and K. Soderhall An Ancient Role for a Prokineticin Domain in Invertebrate Hematopoiesis J. Immunol., May 15, 2005; 174(10): 6153 - 6160. [Abstract] [Full Text] [PDF]

				G. T. Cottrell, Q.-Y. Zhou, and A. V. Ferguson Prokineticin 2 Modulates the Excitability of Subfornical Organ Neurons J. Neurosci., March 10, 2004; 24(10): 2375 - 2379. [Abstract] [Full Text] [PDF]